Innovative Methods to Assess Psychotherapy Practices (imAPP)

October 28, 2022 updated by: Shannon Wiltsey Stirman, Palo Alto Veterans Institute for Research

Leveraging Routine Clinical Materials and Mobile Technology to Assess CBT Quality

This project compares two methods of assessing the quality of cognitive behavioral therapy (CBT) that do not involve directly observing sessions: 1) adherence checklists embedded in clinical notes, and 2) rating the quality of worksheets that are completed with therapist guidance during sessions. It also examines whether ratings of worksheets completed on a mobile app are reliable and valid quality measures. This information can inform strategies to monitor and enhance CBT quality, which can ultimately improve the quality of care and clinical outcomes.

Study Overview

Detailed Description

Cognitive Behavioral Therapy (CBT) has been demonstrated to be effective for numerous presenting problems, including depression, anxiety, and post-traumatic stress disorder (PTSD). Several large mental health systems have invested heavily in programs to train their clinicians in CBTs, but relatively little attention has been devoted to the monitoring or promotion of CBT quality after training is complete. Identifying strategies to do so can facilitate research and training, and is critical to ensuring consumer access to high quality, evidence-based treatments. The lack of a scalable, effective, and efficient method of monitoring quality is a key barrier to efforts to promote high-quality implementation. Self-report fidelity assessments increase clinician and consumer burden and may not accurately reflect clinician skill or the intensity with which CBT interventions are delivered. Observation and expert ratings are time and resource intensive and unlikely to be feasible or affordable in large systems. To maximize the likelihood of broad implementation once effective strategies to monitor quality are established, it is essential that these strategies are feasible and acceptable in routine care contexts, leveraging information collected during routine care. To date, few monitoring strategies that do not involve observation, client/caregiver reports, or clinician self-reports have been tested. To address this critical implementation challenge, we propose to refine and evaluate a method of monitoring quality that is based on an evaluation of CBT worksheets that are completed in session. Because the worksheets were developed to implement core cognitive and behavioral elements and are embedded in CBTs across diagnostic categories, they may be used to elucidate the clinician's ability to guide the client through CBT interventions in session. Preliminary research with this measure demonstrated high correlations between the measure and observer ratings of clinician competence, associations with subsequent symptom change, and high agreement between raters with differing levels of familiarity with CBT. Completion of the ratings based on worksheets requires only a small fraction of time required for session observation and ratings. This project will compare this novel strategy to observer ratings and adherence checklists that are embedded in clinical notes. Furthermore, it will compare the accuracy of worksheet data collected by mobile app to paper-form worksheets, and assess the feasibility and acceptability of these strategies. Because the core elements of CBT and its worksheets are common across many CBTs, this research has broad implications for monitoring fidelity to CBTs in a variety of mental health and healthcare systems and settings. This research will be conducted by a team of investigators with expertise in CBT, training, implementation, psychotherapy process and outcome research, psychometrics, longitudinal data analysis, mobile technologies and healthcare economics, with input from community partners and end-users. The resulting products have the potential to significantly improve efforts to monitor and ensure ongoing high quality implementation of CBT in routine care settings.

Study Type

Observational

Enrollment (Actual)

439

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Palo Alto, California, United States, 94304
        • VA Palo Alto Health Care System
    • Massachusetts
      • Boston, Massachusetts, United States, 02130
        • NCPTSD - VA Boston HCS
      • Chelsea, Massachusetts, United States, 02150
        • Massachusetts General Hospital
    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Aaron T. Beck Psychopathology Research Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Therapists who provide Cognitive Behavioral Therapy, and their patients who receive CBT for depression, anxiety, or PTSD. Therapists and patients will be recruited from community-based, public mental health (e.g., Boston and Palo Alto VA) and private practice treatment settings.

Description

Inclusion Criteria:

A. Clinician eligibility:

  • Private practice or employment at an agency at which the administration agrees to allow the recruitment and participation of their providers in research related activities
  • English Speaking
  • No anticipated plans to leave their current agency for at least 18 months
  • Willingness to allow their CBT sessions, worksheets, surveys, and interview data, and clinical notes to be used for research purposes
  • Carry a caseload that typically includes patients who experience depression, anxiety, or PTSD, with whom they regularly conduct individual therapy sessions and/or capacity to increase the proportion of such patients (e.g., clinic sees a substantial number of individuals with PTSD or depression)
  • Must be trained (worksheet or web-based training and consultation) or in training for Cognitive Processing Therapy (CPT) for PTSD or CBT for depression or anxiety that uses worksheets Does not include CBT-i Can include aspects (i.e., worksheets) of CBT for substance use as long as depression or anxiety is primary diagnoses
  • Must anticipate at least 3 eligible patients
  • Must be willing to record sessions and provide worksheets and symptom measures to the study
  • Must have computer and internet access
  • Must be willing to use a mobile app on a tablet or mobile device

B. Patient eligibility:

  • Must be 18 yrs. of age or older
  • Experience one or more of the following (both a diagnosis and cut off score):

Clinician diagnosis of primary PTSD (PTSD-Checklist-5 score of 33 or more) Depressive disorder (e.g., major depressive disorder, dysthymia; PHQ of 10 or above) Or an Anxiety Disorder (Beck Anxiety Disorder score of 22 or above)

  • Note that if a patient has a score close to the cut-off score, it's up to the therapist digression

    • Must be willing to allow the team to collect session recordings, measures, notes and worksheets
    • Must be able to read and write at a sixth-grade level or above
    • Able to participate in sessions conducted in English, or Spanish (if working with bilingual clinicians in community or private practice)
    • Must be willing to engage in CBT/CPT
    • Therapist considers the treatment with the individual patient to be "mostly" CBT or CPT

Cannot have*:

- Imminent risk of suicide or homicide (requiring hospitalization) that require immediate treatment In need of detoxification (can be enrolled when substance abuse treatment is not the primary treatment target) Active psychosis or manic episode unless well controlled by medication and not the primary focus of treatment Cognitive impairments that preclude any participation in therapy

C. Administrator eligibility:

  • Must have a support or managerial/supervisory position at the clinic(s) from which A and B are being recruited from
  • Must also be willing to complete a packet of study measures/partake in an interview

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Ecologic or Community
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
App Condition
Although we will be mostly observing routine practice, we will randomize patients into either an App condition or paper condition. The App condition refers to patients completing routine Cognitive Behavioral Therapy (CBT) worksheets on a mobile application during session. Everything else that occurs in treatment sessions will be consistent with routine care practices.
Cognitive Behavioral Therapy (CBT) is an evidence-based psychotherapy that treats a variety of disorders. In this study, clinicians will be enrolled who use types of CBT for anxiety disorders, depression and PTSD in their routine clinical practice. CBT is usually a 12-16 session treatment that focuses on intervening on disorders cognitively and behaviorally through the use of worksheets during session and outside of session.
Other Names:
  • Cognitive Processing Therapy
Paper Condition
Although we will be mostly observing routine practice, we do randomize patients into either an App condition or paper condition. The paper condition refers to patients completing routine CBT worksheets on paper (the current standard) during session.
Cognitive Behavioral Therapy (CBT) is an evidence-based psychotherapy that treats a variety of disorders. In this study, clinicians will be enrolled who use types of CBT for anxiety disorders, depression and PTSD in their routine clinical practice. CBT is usually a 12-16 session treatment that focuses on intervening on disorders cognitively and behaviorally through the use of worksheets during session and outside of session.
Other Names:
  • Cognitive Processing Therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Patient Health Questionnaire (PHQ-9)
Time Frame: Baseline (pre-treatment), Every session (weekly) if primary /target problem up to 16 weeks
9-item self-report measure of depression symptoms with good internal reliability (α = .89) and test-retest reliability (r = .84).
Baseline (pre-treatment), Every session (weekly) if primary /target problem up to 16 weeks
Change in Posttraumatic Stress Disorder Checklist (PCL-5)
Time Frame: Baseline (pre-treatment), Every session (weekly) if primary /target problem up to 16 weeks
A 20-item self-report measure that assesses the 20 Diagnostic and Statistical Manual (DSM-5) symptoms of PTSD. Good internal consistency and concurrent validity with the Clinician-assessed PTSD Scale.
Baseline (pre-treatment), Every session (weekly) if primary /target problem up to 16 weeks
Change in Beck Anxiety Inventory
Time Frame: Baseline (pre-treatment), Every session (weekly) if primary /target problem up to 16 weeks
21-item self-report instrument for measuring the severity of anxiety symptoms. Good internal consistency (α = .92) and high test-retest reliability (r = .75.).
Baseline (pre-treatment), Every session (weekly) if primary /target problem up to 16 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Inventory of Psycho social Functioning-Brief Version
Time Frame: Completed at baseline, One Month, and post-treatment (week 16)
14 items, yields a grand mean and 7 subscale means for functioning in romance, family, friendships, parenting, education, work, and self-care activities (non-applicable categories can be skipped; total score reflects mean of applicable items). Excellent reliability and internal consistency ( α = 0.93); correlates with other measures of quality of life.
Completed at baseline, One Month, and post-treatment (week 16)
Evidence-Based Practice Attitudes Scale-50 (EBPAS)
Time Frame: Completed at therapist baseline (prior to providing treatment in the study)
This measure looks at Evidence-based practice attitudes and motivation among clinicians, 1 (worse)-5 (best) total score range
Completed at therapist baseline (prior to providing treatment in the study)
Perceived Characteristics of Interventions (PCIS)
Time Frame: Completed at therapist baseline (prior to providing treatment in the study)
Innovation characteristics hypothesized to influence adoption and sustainability
Completed at therapist baseline (prior to providing treatment in the study)
Implementation Climate Assessment (ICA)
Time Frame: Completed at therapist baseline (prior to providing treatment in the study)
Brief validated measure of implementation climate ( manager support for EBPs, etc.)
Completed at therapist baseline (prior to providing treatment in the study)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Shannon W Stirman, PhD, NCPTSD/Stanford University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2017

Primary Completion (Actual)

December 15, 2021

Study Completion (Anticipated)

October 15, 2023

Study Registration Dates

First Submitted

March 8, 2018

First Submitted That Met QC Criteria

March 20, 2018

First Posted (Actual)

March 27, 2018

Study Record Updates

Last Update Posted (Actual)

November 3, 2022

Last Update Submitted That Met QC Criteria

October 28, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • WIS0003AGG
  • R01MH112628 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mobile Application-Based CBT Worksheet Collection

Clinical Trials on Cognitive Behavioral Therapy

3
Subscribe